Relevant preclinical models for efficacy studies of new drugs
Innovative medical devices targeting diabetes and metabolic diseases
DiabInnov is a research platform focused on innovative strategies for the treatment of metabolic disorders and their comorbidities to provide significant advance in patient care.
Our mission is to place fundamental, preclinical and clinical research in metabolism at the service of life science companies, and academia. We enable discovering of new pharmacological targets, testing novel compounds in innovant preclinical models, and accelerating safety and efficacy testing of innovative medical devices.
DiabInnov promotes dialogue between pharmaceutical companies and innovative medical devices manufacturers on one side and scientists, researchers and surgeons and the other. This biomedical gateway to biotechnological innovation facilitates the obtaining of patents, the acceleration of CE marking, the implementation of new surgical approaches and a know-how of excellence.
β-cell and α-cell function and dynamic hormone secretion
Islet cell viability and apoptosis and pancreatic histopathological evaluation
Human pancreatic islet transplantation and function evaluation in vivo
Adaptative β-cell proliferation in vivo and metabolic evaluation
Metabolically Healthy and Unhealthy Obesity
Medical Devices development